We are live on ! Find out more
SA

Sicart Associates Portfolio holdings

AUM $389M
1-Year Est. Return 42.46%
This Fund
S&P 500
This Quarter Est. Return
+5.42%
1 Year Est. Return
+42.46%
3 Year Est. Return
+89.06%
5 Year Est. Return
+118.65%
10 Year Est. Return
AUM
$189M
AUM Growth
+$49.6M
Cap. Flow
+$42.6M
Cap. Flow %
22.51%
Top 10 Hldgs %
43.99%
Holding
100
New
27
Increased
42
Reduced
4
Closed
1

Sector Composition

Rank Sector Weight
1 Healthcare 18.92%
2 Technology 17.95%
3 Energy 15.91%
4 Materials 8.04%
5 Industrials 5.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BA icon
26
Boeing
BA
$171B
$2.06M 1.09%
7,000
+3,000
+75% +$812K
DD icon
27
DuPont de Nemours
DD
$18.5B
$2.04M 1.08%
11,340
+5,771
+104% +$1.04M
MCD icon
28
McDonald's
MCD
$192B
$2.04M 1.07%
11,827
+3,000
+34% +$504K
EWQ icon
29
iShares MSCI France ETF
EWQ
$335M
$2.01M 1.06%
64,520
NVS icon
30
Novartis
NVS
$297B
$1.93M 1.02%
25,668
MU icon
31
Micron Technology
MU
$930B
$1.85M 0.98%
45,000
EWU icon
32
iShares MSCI United Kingdom ETF
EWU
$4.14B
$1.8M 0.95%
50,350
JNJ icon
33
Johnson & Johnson
JNJ
$618B
$1.75M 0.93%
12,546
+7,000
+126% +$975K
NUAN
34
DELISTED
Nuance Communications, Inc.
NUAN
$1.65M 0.87%
116,684
+16,748
+17% +$225K
META icon
35
Meta Platforms (Facebook)
META
$1.42T
$1.64M 0.86%
9,270
+4,500
+94% +$795K
PFE icon
36
Pfizer
PFE
$143B
$1.62M 0.85%
47,077
+21,080
+81% +$719K
AFL icon
37
Aflac
AFL
$64.9B
$1.56M 0.82%
35,584
+16,000
+82% +$683K
CAT icon
38
Caterpillar
CAT
$375B
$1.5M 0.79%
9,500
+4,500
+90% +$624K
KYNB
39
Kyntra Bio
KYNB
$27.2M
$1.47M 0.78%
1,243
GG
40
DELISTED
Goldcorp Inc
GG
$1.42M 0.75%
111,000
+10,000
+10% +$129K
ADP icon
41
Automatic Data Processing
ADP
$106B
$1.35M 0.71%
11,500
+6,000
+109% +$686K
WY icon
42
Weyerhaeuser
WY
$18B
$1.27M 0.67%
35,901
+15,000
+72% +$531K
XME icon
43
State Street SPDR S&P Metals & Mining ETF
XME
$3.87B
$1.13M 0.6%
31,000
DIS icon
44
Walt Disney
DIS
$167B
$1.01M 0.53%
9,343
+3,000
+47% +$309K
AMZN icon
45
Amazon
AMZN
$2.92T
$1.01M 0.53%
17,200
+6,000
+54% +$330K
CVX icon
46
Chevron
CVX
$392B
$1M 0.53%
8,000
MMM icon
47
3M
MMM
$90.9B
$1M 0.53%
5,089
+2,990
+142% +$575K
XOM icon
48
ExxonMobil
XOM
$644B
$937K 0.49%
11,200
+2,000
+22% +$165K
CL icon
49
Colgate-Palmolive
CL
$73.1B
$920K 0.49%
12,200
+6,000
+97% +$438K
SCS
50
DELISTED
Steelcase
SCS
$881K 0.47%
57,500
+21,000
+58% +$308K

Similar funds

Sicart Associates's Q4 2017 Portfolio in Review

As of Q4 2017, Sicart Associates held 100 positions worth $189M, up 35% from $140M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Sicart Associates deployed $42.6M of net new capital in Q4 2017, opening 27 new positions and adding to 42 existing holdings. Its largest new stake was ProShares Short High Yield: 335,480 shares worth $7.76M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 24% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was ProShares Short S&P500, an estimated $370K trimmed.

  • Sicart Associates's largest Q4 2017 buy was ProShares Short High Yield: 335,480 shares worth $7.76M.
  • Sicart Associates added most to APA Corp in Q4 2017, an estimated $1.44M increase.
  • Sicart Associates's biggest Q4 2017 reduction was ProShares Short S&P500, cutting an estimated $370K.
  • Sicart Associates fully exited SANGAMO THERAPEUTICS INC in Q4 2017, selling an estimated $157K.
  • Sicart Associates's ten largest holdings make up 44% of its $189M portfolio in Q4 2017.
  • Sicart Associates opened 27 new positions and closed 1 in Q4 2017.
  • Sicart Associates's portfolio value rose 35% quarter-over-quarter to $189M.

Based on Sicart Associates's 13F filing for Q4 2017, filed 17 Jan 2018.